Health technology firm Royal Philips has introduced Ingenia Elition 3.0T MRI solution, which is claimed to improve digital image quality by up to 50%.

Part of the Ingenia digital MR portfolio, the new MR solution presents patient-centric imaging from patient set-up to the final image.

Featuring a newly designed user interface for workflow optimization, Ingenia Elition’s VitalScreen provides operators with fully guided patient setup.

VitalEye technology offers an advanced patient sensing approach, helping to permit respiratory signal without any interaction from the operator.

Through combining dStream digital broadband technology with Compressed SENSE and 3D APT across its digital MR portfolio, Philips is providing its advanced tools for radiologists to solve challenging clinical situations.

Philips’ new patient sensing technology and AI-driven SmartExam analytics for automatic planning, scanning and processing of exams allow to improve the complete MR workflow ranging from image acquisition to reading preference.

The company also recently introduced new Ingenia Prodiva 1.5T MR solution into the market. Both new MR solutions will help enhance productivity and deliver better value-based care through improved patient outcomes.

Philips will officially unveil Ingenia Elition and its newest MR innovations at this year’s European Congress of Radiology event in Vienna, Austria.

Philips MR business leader Arjen Radder said: “As value-based care initiatives challenge healthcare organizations to drive better outcomes, radiology departments are specifically caught between ever-increasing imaging volume demands, while also facing pressure to engage more deeply with both referring physicians and patients.

“Philips is responding to these challenges through the development of solutions such as Ingenia Elition to improve image quality and the patient and staff experience, as well as operational efficiency.” 

In January this year, Philips unveiled plans to develop a new research and development (R&D) facility in the US for its computed tomography and advanced molecular imaging (CT/AMI) businesses.

The facility which will be built in Cleveland of Ohio will be part of the company’s commitment to innovation with an annual $600m R&D spend in North America.

Image: Philips Ingenia Elition 3.0T MR solution offers a breakthrough in speed, patient experience and clinical confidence. Photo: courtesy of Koninklijke Philips N.V.